American Society of Clinical Oncology

SHERPA: White

People

  1. Bluth
    Bluth
  2. Panageas
    Panageas
  3. Bajorin
    Bajorin
  4. Funt
    Funt
  5. Iyer
    Iyer
  6. Rosenberg
    Rosenberg
  7. Abramson
    Abramson
  8. Al-Ahmadie
    Al-Ahmadie
  9. Berger
    Berger
  10. Chaim
    Chaim

Groups

  1. Body Imaging Service (9)
  2. Department of Medicine (9)
  3. GSK Faculty (9)
  4. Melanoma and Immunotherapeutics Service (9)
  5. Radiology, Department of (9)
  6. Solid Tumor Oncology Division (9)
  7. Biostatistics Service (7)
  8. Epidemiology and Biostatistics (7)
  9. Population Sciences Research Program (6)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
Search Within
  1. "Body Imaging Service"
  2. "Jedd Wolchok"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (2)
Groups
  1. Body Imaging Service (9)
  2. Department of Medicine (9)
  3. GSK Faculty (9)
  4. Melanoma and Immunotherapeutics Service (9)
  5. Radiology, Department of (9)
  6. Solid Tumor Oncology Division (9)

More Groups

People
  1. Jedd Wolchok (9)
  2. Margaret Callahan (5)
  3. Mark Bluth (5)
  4. Gary Schwartz (4)
  5. Katherine Panageas (4)
  6. Paul Chapman (4)

More People

Years
  1. 2019 (2)
  2. 2018 (2)
  3. 2014 (2)
  4. 2012 (2)
  5. 2009 (1)
Publications
  1. Journal of Clinical Oncology (9)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot safety study of gemcitabine and cisplatin (GC) with atezolizumab (A) as first-line therapy in patients (pts) with metastatic urothelial cancer (mUC)
    Meeting Abstract

    Funt, S. A.; Jatwani, K.; Makris, M.; Regazzi, A. M.; Lee, C. H.; Teo, M. Y.; McHugh, D. J.; McCoy, A. S.; Hettich, G.; Wong, P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Durable clinical benefit from combination ipilimumab (IPI) and nivolumab (NIVO) in anti-PD-1 therapy resistant, platinum resistant metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Keegan, N. M.; Funt, S. A.; Kania, B. E.; Iyer, G.; Clement, J. M.; McCoy, A. S.; Hettich, G.; Ziv, E.; Maher, C. A.; Nair, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Alterations in DNA damage response and repair genes as potential marker of clinical benefit from PD-1/PD-L1 blockade in advanced urothelial cancers
    Journal Article

    Teo, M. Y.; Seier, K.; Ostrovnaya, I.; Regazzi, A. M.; Kania, B. E.; Moran, M. M.; Cipolla, C. K.; Bluth, M. J.; Chaim, J.; Al-Ahmadie, H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
    Journal Article

    Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The Memorial Sloan Kettering Cancer Center (MSKCC) experience of systemic therapy in mucosal melanoma
    Meeting Abstract

    Bitas, C.; Shoushtari, A. N.; Bluth, M. J.; Bhuchar, G.; Hester, R. H.; Romero, J.; Fitzpatrick, L.; Lefkowitz, R. A.; Panageas, K.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Safety and clinical activity of combining systemic ipilimumab with isolated limb infusion in patients with in-transit melanoma
    Meeting Abstract

    Ariyan, C. E.; Lefkowitz, R. A.; Panageas, K.; Callahan, M. K.; Misholy, O.; Bello, D.; Fisher, C.; Kotin, A.; Siegelbaum, R.; Coit, D. G.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Pharmacodynamic activity of selumetinib to predict radiographic response in advanced uveal melanoma
    Meeting Abstract

    Carvajal, R. D.; Ambrosini, G.; Wolchok, J. D.; Chapman, P. B.; Dickson, M. A.; D'Angelo, S. P.; Bluth, M. J.; Paucar, D.; Fusco, A.; Bohr, D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Ipilimumab in the treatment of uveal melanoma: The Memorial Sloan-Kettering Cancer Center experience
    Meeting Abstract

    Khan, S. A.; Callahan, M.; Postow, M. A.; Chapman, P. B.; Schwartz, G. K.; Dickson, M. A.; D'Angelo, S. P.; Luke, J. J.; Bluth, M. J.; Roman, R. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase II study of imatinib mesylate (IM) for patients with advanced melanoma harboring somatic alterations of KIT
    Meeting Abstract

    Carvajal, R. D.; Chapman, P. B.; Wolchok, J. D.; Cane, L.; Teitcher, J. B.; Lutzky, J.; Pavlick, A. C.; Bastian, B. C.; Antonescu, C. R.; Schwartz, G. K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save